The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Open accessAbstract
Prevailing theories suggest that luminal cells are the origin of prostate cancer because it is histologically defined by basal cell loss and malignant luminal cell expansion. We introduced a series of genetic alterations into prospectively identified populations of murine basal/stem and luminal cells in an in vivo prostate regeneration assay. Stromal induction of FGF signaling, increased expression of the ETS family transcription factor ERG1, and constitutive activation of PI3K signaling were evaluated. Combination of activated PI3K signaling and heightened androgen receptor signaling, which is associated with disease progression to androgen independence, was also performed. Even though luminal cells fail to respond, basal/stem cells demonstrate efficient capacity for cancer initiation and can produce luminal-like disease characteristic of human prostate cancer in multiple models. This finding provides evidence in support of basal epithelial stem cells as one target cell for prostate cancer initiation and demonstrates the propensity of primitive cells for tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 1×
“(3) used this approach to demonstrate that BCR-ABL can induce myeloid disease in mice when introduced into HSC but not more committed progenitors, while other fusion oncogenes can initiate disease from both stem cells and progenitors (4, 5).”
MethodA luminal epithelial stem cell that is a cell of origin for prostate cancer
Wang, X., Julio, M. K.-D., Economides, K. D., Walker, D., Yu, H., Halili, M. V., Hu, Y.-P., Price, S. M., Abate-Shen, C., & Shen, M. M. (2009) · Nature · doi:10.1038/nature08361 · Cited by 734
Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*
KYPRIANOU, N., & ISAACS, J. T. (1988) · Endocrinology · doi:10.1210/endo-122-2-552 · Cited by 720
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., et al. (2008) · Neoplasia · doi:10.1593/neo.07822 · Cited by 690
Cozzio, A., Passegué, E., Ayton, P. M., Karsunky, H., Cleary, M. L., & Weissman, I. L. (2003) · Genes & Development · doi:10.1101/gad.1143403 · Cited by 663
Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 531
Xin, L., Lawson, D. A., & Witte, O. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502320102 · Cited by 423
Self-citationIsolation and functional characterization of murine prostate stem cells
Lawson, D. A., Xin, L., Lukacs, R. U., Cheng, D., & Witte, O. N. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609684104 · Cited by 399
Self-citationEnglish, H. F., Santen, R. J., & Lsaacs, J. T. (1987) · The Prostate · doi:10.1002/pros.2990110304 · Cited by 354
Wang, S., Garcia, A. J., Wu, M., Lawson, D. A., Witte, O. N., & Wu, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510652103 · Cited by 308
Self-citationProximal location of mouse prostate epithelial stem cells
Tsujimura, A., Koikawa, Y., Salm, S., Takao, T., Coetzee, S., Moscatelli, D., Shapiro, E., Lepor, H., Sun, T.-T., & Wilson, E. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202067 · Cited by 305
A causal role for ERG in neoplastic transformation of prostate epithelium
Klezovitch, O., Risk, M., Coleman, I., Lucas, J. M., Null, M., True, L. D., Nelson, P. S., & Vasioukhin, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711711105 · Cited by 302
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
Majumder, P. K., Yeh, J. J., George, D. J., Febbo, P. G., Kum, J., Xue, Q., Bikoff, R., Ma, H., Kantoff, P. W., Golub, T. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232229100 · Cited by 285
PTEN, a unique tumor suppressor gene.
Dahia, P. L. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070115 · Cited by 283
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203 · cited 1×
“The FU-CGW, FU-CRW, FU-mAKT1-CGW, FU-AR-CGW, andFU-ERG1-CRW lentiviral vectors, and the MSCV-FGF10 retroviral vector have been described previously (13, 26, 35).”
MethodSelf-citationMemarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201
Self-citationXin, L., Ide, H., Kim, Y., Dubey, P., & Witte, O. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734139100 · Cited by 195
Self-citationMulholland, D. J., Xin, L., Morim, A., Lawson, D., Witte, O., & Wu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4673 · Cited by 179
Self-citationFGF-10 plays an essential role in the growth of the fetal prostate
Donjacour, A. A., Thomson, A. A., & Cunha, G. R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00250-1 · Cited by 170
van Leenders, G., Dijkman, H., Hulsbergen-van de Kaa, C., Ruiter, D., & Schalken, J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780133 · Cited by 169
Xin, L., Teitell, M. A., Lawson, D. A., Kwon, A., Mellinghoff, I. K., & Witte, O. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602567103 · Cited by 158
Self-citationDo different branching epithelia use a conserved developmental mechanism?
Davies, J. A. (2002) · BioEssays · doi:10.1002/bies.10161 · Cited by 141
Morphological features of TMPRSS2–ERG gene fusion prostate cancer
Mosquera, J. M., Perner, S., Demichelis, F., Kim, R., Hofer, M. D., Mertz, K. D., Paris, P., Simko, J., Collins, C. C., Bismar, T., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2154 · Cited by 129
Bonkhoff, H., & REMBERGER, K. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01605130 · Cited by 126
Keratin profiles in normal/hyperplastic prostates and prostate carcinoma
Okada, H., Tsubura, A., Okamura, A., et al. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01607049 · Cited by 103
Zhou, Z., Flesken-Nikitin, A., & Nikitin, A. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0768 · Cited by 91
Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates
Masai, M., Sumiya, H., Akimoto, S., Yatani, R., Chang, C., Liao, S., & Shimazaki, J. (1990) · The Prostate · doi:10.1002/pros.2990170405 · Cited by 91
Korsten, H., der Made, A. Z., Ma, X., van der Kwast, T., & Trapman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005662 · Cited by 86
Negri‐Cesi, P., Poletti, A., Colciago, A., Magni, P., Martini, P. G. V., & Motta, M. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980301)34:4<292::aid-pros7>3.0.co;2-j · Cited by 74
Transgenic Mouse Model for Rapid Pharmacodynamic Evaluation of Antiandrogens
Ellwood‐Yen, K., Wongvipat, J., & Sawyers, C. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1397 · Cited by 35
Progenitor Cells for the Prostate Epithelium: Roles in Development, Regeneration, and Cancer
Shen, M. M., Wang, X., Economides, K. D., Walker, D., & Abate-Shen, C. T. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.050 · Cited by 33
Cited by
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Bluemn, E. G., Coleman, I. M., Lucas, J. M., Coleman, R. T., Hernandez-Lopez, S., Tharakan, R., Bianchi-Frias, D., Dumpit, R. F., Kaipainen, A., Corella, A. N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.003 · Cited by 744
“Notably, a small subset of CRPCs exhibiting FGFR/MAPK activity did not express high levels of FGF ligands, suggesting that in some circumstances paracrine FGF derived from microenvironment constituents may promote pathway activity and drive treatment resistance (Lawson et al., 2010).”
Background
Metadata
- Authors
- Lawson, D. A., Zong, Y., Memarzadeh, S., Xin, L., Huang, J., & Witte, O. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-25
- Volume
- 107
- Issue
- 6
- Pages
- 2610-2615
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2039015433
- Cited by
- 275
- References
- 35
- FWCI
- 30.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.